000 | 01952 a2200541 4500 | ||
---|---|---|---|
005 | 20250516164059.0 | ||
264 | 0 | _c20140904 | |
008 | 201409s 0 0 eng d | ||
022 | _a1935-469X | ||
024 | 7 |
_a10.1200/JOP.2013.001047 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aMurphy, Caitlin C | |
245 | 0 | 0 |
_aPretreatment patient comorbidity and tobacco use increase cost and risk of postoperative complications after esophagectomy at a high-volume cancer center. _h[electronic resource] |
260 |
_bJournal of oncology practice _cSep 2013 |
||
300 |
_a233-9 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAdenocarcinoma _xeconomics |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 |
_aAnastomotic Leak _xeconomics |
650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
650 | 0 | 4 |
_aCancer Care Facilities _xeconomics |
650 | 0 | 4 |
_aCisplatin _xadministration & dosage |
650 | 0 | 4 | _aCombined Modality Therapy |
650 | 0 | 4 | _aComorbidity |
650 | 0 | 4 |
_aEsophageal Neoplasms _xeconomics |
650 | 0 | 4 |
_aEsophagectomy _xadverse effects |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aFluorouracil _xadministration & dosage |
650 | 0 | 4 | _aHospital Costs |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aLength of Stay |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aOrganoplatinum Compounds _xadministration & dosage |
650 | 0 | 4 | _aOxaliplatin |
650 | 0 | 4 |
_aPostoperative Complications _xeconomics |
650 | 0 | 4 | _aRisk |
650 | 0 | 4 |
_aTaxoids _xadministration & dosage |
650 | 0 | 4 |
_aTobacco Use _xeconomics |
700 | 1 | _aIncalcaterra, James R | |
700 | 1 | _aAlbright, Heidi W | |
700 | 1 | _aCorrea, Arlene M | |
700 | 1 | _aSwisher, Stephen G | |
700 | 1 | _aHofstetter, Wayne L | |
773 | 0 |
_tJournal of oncology practice _gvol. 9 _gno. 5 _gp. 233-9 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1200/JOP.2013.001047 _zAvailable from publisher's website |
999 |
_c23002863 _d23002863 |